American Heart Association Report Finds Ultromics EchoGo May Detect HFpEF Earlier
The American Heart Association has released an AI Impact Report assessing Ultromics' EchoGo Heart Failure system. The findings, announced in a press release, show that the AI tool could detect heart failure with preserved ejection fraction (HFpEF) about 263 days earlier than standard diagnostic methods.
The analysis used retrospective real world data from Dandelion Health and was conducted through the American Heart Association's AI Assessment Lab. This evaluation estimated that earlier detection could lead to nearly 500 additional lives saved for every 10,000 patients under the modeled assumptions.
The report also projected potential financial benefits for health systems, estimating up to about 1.9 million dollars in additional revenue over five years. The assessment aimed to quantify both the clinical and economic value of cardiovascular AI tools like EchoGo Heart Failure in routine care.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Brainomix and Pulmonary Fibrosis Foundation Partner on AI Lung Imaging Research
Rhythm AI Study Reports 90% Freedom From Atrial Fibrillation
LUNGevity Awards $2 Million for Lung Nodule Risk Studies
Helio Genomics Presents Four HelioLiver Studies on Liver Cancer Detection
Omega Healthcare Wins Gold in 2026 AI Breakthrough Awards
Daily AI Brief: the AI news that matters, in your inbox.